AGA Recommends Fecal Microbiota Transplant for Recurrent C. Difficile
MONDAY, Feb. 26, 2024 -- Fecal microbiota transplant is recommended on completion of standard-of-care antibiotics to prevent recurrence for adults with recurrent Clostridioides difficile (C. difficile) infection, according to a clinical practice... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 26, 2024 Category: Pharmaceuticals Source Type: news
Doxycycline Tied to Lower Risk for C. Difficile in Pneumonia Patients
THURSDAY, Nov. 30, 2023 -- For patients with community-acquired pneumonia (CAP), doxycycline is associated with a reduced risk for Clostridioides difficile infection (CDI), according to a study published online Nov. 1 in the American Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 30, 2023 Category: Pharmaceuticals Source Type: news
Patient-to-Patient Transmission Not to Blame for Most C. Difficile Infections in Hospitals
WEDNESDAY, Sept. 20, 2023 -- A deadly infection associated with hospitalization may not be the fault of the hospital, but may instead stem from the patients themselves, a new study suggests.
Infection caused by the bacterium Clostridioides... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 20, 2023 Category: General Medicine Source Type: news
Child Develops Voluminous Diarrhea After Amoxicillin
(MedPage Today) -- Discordant test results complicate diagnosis of suspected C. difficile (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - September 18, 2023 Category: Gastroenterology Source Type: news
Miami Medical Clinic Owner and Pharmacist Convicted for Clinical Trial Fraud Scheme
FDA OCI, Miguel Angel Montalvo Villa, Ivette Maria Portela Martinez, Miami, FL, guilty, falsification, fabrication, clinical trial, data, conspiracy, wire fraud, jury, convict, verdict, AMB Research Center, AMB, pharmacist, data entry specialist, treat, Clostridium difficile-associated diarrhea, CDA (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - September 11, 2023 Category: Medical Law Authors: DOJ Source Type: news
Factors Associated With the Outcome of FMT for C. Difficile Factors Associated With the Outcome of FMT for C. Difficile
What factors might impact the variation in effectiveness of fecal microbiota transplantation in patients with recurrent C. difficile infection?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 5, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
The Establishment Failed Pel é And Kristie
I was saddened to hear that soccer legend Pelé and “Cheers” star Kirstie Alley both died of colon cancer late last year.
But the wider part of this tragedy is that this kind of cancer is highly preventable and still poorly understood by most doctors.
Mainstream physicians – as well as the media – will tell you your age causes colon cancer, the genes you inherited from your family, and a high-fat diet.
They couldn’t be more wrong.
Colorectal cancer has nothing to do with age and very little to do with your genes…
Instead, it has everything to do with epigenetics.
This is the important relationship between o...
Source: Al Sears, MD Natural Remedies - August 25, 2023 Category: Complementary Medicine Authors: Jacob Tags: Cancer Source Type: news
New and Emerging Options for Treating Recurrent C difficile New and Emerging Options for Treating Recurrent C difficile
Paul G. Auwaerter, MD, discusses treatment options for recurrent C difficile, including new FDA-approved fecal microbiota products.Medscape Infectious Diseases (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - July 28, 2023 Category: Infectious Diseases Tags: Infectious Diseases Commentary Source Type: news
How NSAIDs Can Make a C. Difficile Infection Worse
FRIDAY, July 21, 2023 -- Aspirin, naproxen and other common pain medications known as NSAIDs worsen gastrointestinal infections caused by a bacterium known as Clostridioides difficile (C. diff), new research shows.
NSAIDs (nonsteroidal... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 21, 2023 Category: General Medicine Source Type: news
Unraveling the Mechanisms Behind FMT Efficacy Unraveling the Mechanisms Behind FMT Efficacy
Already successful in treating C difficile, fecal microbiota transplant could be applied to noncommunicable diseases, but better understanding of donor-recipient pairing is critical.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 7, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Allowing Bedside Nurses to Order C. Difficile Testing Cuts Time to Results
FRIDAY, May 26, 2023 -- Allowing bedside nurses to independently order stool testing for Clostridioides difficile (C. difficile) significantly decreases the amount of time to receive test results versus requiring physician approval, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 26, 2023 Category: Pharmaceuticals Source Type: news
Fecal Microbiota Transplantation Aids Resolution of Recurrent C. Difficile
TUESDAY, May 16, 2023 -- For immunocompetent adults with recurrent Clostridioides difficile infection (rCDI), fecal microbiota transplantation (FMT) yields a significant increase in resolution compared with alternative treatments, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 16, 2023 Category: Pharmaceuticals Source Type: news
FMT in a Pill: FDA OKs Second Product to Prevent Recurrent C difficile FMT in a Pill: FDA OKs Second Product to Prevent Recurrent C difficile
Clinicians now have two approved options for recurrent infections after antibiotic treatment.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 29, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
FDA Approves Treatment for Deadly C. Difficile Infections FDA Approves Treatment for Deadly C. Difficile Infections
The FDA on Wednesday approved Seres Therapeutics ' s pill for treating a type of bacterial infection, giving an easier and standardized option to patients who often have to rely on individual donors for fecal transplants.Reuters Health Information (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - April 27, 2023 Category: Infectious Diseases Tags: Infectious Diseases News Alert Source Type: news
FDA Approves First Pill for the Microbiome
Probiotics have long been star ingredients in dairy foods, drinks, and supplements, promising to generate a better bacterial balance to our guts.
On Apr. 26, the U.S. Food and Drug Administration (FDA) took a step toward formalizing the idea of adjusting gut-bacteria populations when it approved the first oral drug designed to treat the microbiome. Called SER-109, the pill is a cocktail of bacteria that can prevent recurring infections of C. difficile bacteria in people who have had previous episodes, and help them maintain healthy levels of gut bacteria. Keeping beneficial bacteria in proper balance could be an important ...
Source: TIME: Health - April 27, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Drugs healthscienceclimate Source Type: news
